Year: 2019
Type: article
Abstract: Understanding the foreign body response (FBR) and desiging strategies to modulate such a response represent a grand challenge for implant devices and biomaterials. Here, the development of a microfluidic platform is reported, i.e., the FBR-on-a-chip (FBROC) for modeling the cascade of events during immune cell response to implants. The platform models the native implant microenvironment where the implants are interfaced directly with surrounding tissues, as well as vasculature with circulating immune cells. The study demonstrates that the release of cytokines such as monocyte chemoattractant protein 1 (MCP-1) from the extracellular matrix (ECM)-like hydrogels in the bottom tissue chamber induces trans-endothelial migration of circulating monocytes in the vascular channel toward the hydrogels, thus mimicking implant-induced inflammation. Data using patient-derived peripheral blood mononuclear cells further reveal inter-patient differences in FBR, highlighting the potential of this platform for monitoring FBR in a personalized manner. The prototype FBROC platform provides an enabling strategy to interrogate FBR on various implants, including biomaterials and engineered tissue constructs, in a physiologically relevant and individual-specific manner.
Source: Advanced Healthcare Materials
Institutions: Brigham and Women's Hospital, Sharif University of Technology, Harvard University, University of Nottingham, Ege University, California NanoSystems Institute, University of California, Los Angeles, Scuola Superiore Sant'Anna, Konkuk University, Inserm, Protip Medical (France), Biomatériaux et Bioingénierie, Université de Strasbourg, Research Institute for Bioscience and Biotechnology, Zhejiang University
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: green
Funders: European Commission, National Institutes of Health, Horizon 2020 Framework Programme, Fundamental Research Funds for the Central Universities, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute of Dental and Craniofacial Research
Awards: Smart wound dressing for treating chronic diabetic ulcers, Recapitulating Ductal Carcinoma on a Chip for Personalized Breast Cancer Therapy, Programmable multimaterial bioprinting of 3D vascularized tissue constructs, Angiogenic Biomaterials as Dermal Scaffolds to Enhance Diabetic Wound Healing, High-Throughput Microenvironment Regulation for Chondrogenesis, G3006593996, G302395814, Engineering Vascularized Bone Tissues By Microfabrication And Scaffolding, Catheter guided endovascular electric field ablation for thrombosis therapy., Oxygen generating bioinks for 3D printed bone implants, Personalized And/Or Generalized Integrated Biomaterial Risk Assessment, Developing Hybrids of Cardiac Tissue and Biodegradable Electronics Towards Heart Implants with On-line Monitoring and Stimulating Functions, Recapitulating Ductal Carcinoma on a Chip for Personalized Breast Cancer Therapy, Microengineered Osteons for Bone Tissue Engineering, Multiscale Stereolithogrphic Bioprinting of Stage-Matching Vascularized Tumor Models, Local Immunomodulation around implants by innovative auxiliary hydrogel-based systems encapsulating autologous and phenotype controlled macrophages, G9000249555
OpenAlex ID: W2911756089
